Synergy Between Human Monoclonal Antibodies to HIV Extends Their Effective Biologic Activity Against Homologous and Divergent Strains
- 1 April 1992
- journal article
- letter
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 8 (4) , 425-427
- https://doi.org/10.1089/aid.1992.8.425
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Genomic diversity and antigenic variation of HIV‐1: links between pathogenesis, epidemiology and vaccine developmentThe FASEB Journal, 1991
- Neutralization of HIV‐1: a paradox of humoral proportionsThe FASEB Journal, 1991
- Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.Proceedings of the National Academy of Sciences, 1991
- Identification of Conserved and Variant Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 by Human Monoclonal Antibodies Produced by EBV-Transformed Cell LinesAIDS Research and Human Retroviruses, 1990
- Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.Proceedings of the National Academy of Sciences, 1990
- Topographical and Functional Mapping of Epitopes on Hog Cholera Virus with Monoclonal AntibodiesJournal of General Virology, 1989
- Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 VirusJournal of General Virology, 1988
- Simple, Rapid, Quantitative, Syncytium-Forming Microassay for the Detection of Human Immunodeficiency Virus Neutralizing AntibodyAIDS Research and Human Retroviruses, 1987
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- A Multi-Hit Model for the Neutralization of Animal VirusesJournal of General Virology, 1978